Efficacy and safety of JR-051, a biosimilar of agalsidase...

Efficacy and safety of JR-051, a biosimilar of agalsidase beta, in patients with Fabry disease; results of a multicenter, open-label phase 3 study in Japan

Kobayashi, Minako, Yamamoto, Tatsuyoshi, Yamaoka, Mariko, Tomio, Teiji
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
123
Language:
english
Journal:
Molecular Genetics and Metabolism
DOI:
10.1016/j.ymgme.2017.12.201
Date:
February, 2018
File:
PDF, 51 KB
english, 2018
Conversion to is in progress
Conversion to is failed